New treatments for treatment-resistant depression: esketamine controversies – a narrative review
Danish Medical Journal · 2026-08 · 1-9
DOI: 10.61409/a02260078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Danish Medical Journal, 2026-08. Verfasst von Maj Vinberg. Beteiligte Einrichtung: The Early Multimodular Prevention and Intervention Research Institution (EMPIRI), Psychiatric Centre North Zealand, Copenhagen University Hospital - …. Hauptthemen laut MEDLINE: Depressive Disorder, Treatment-Resistant, Ketamine, Antidepressive Agents.
Themen: Depression
Abstract (Originalsprache)
This narrative review examines barriers to Danish patients’ timely access to new treatments for treatment-resistant depression, focusing on controversies around esketamine. Delays arise from regulatory complexity, economic constraints and scientific debate over novel psychotropics. The review advocates evidence-based, faster implementation pathways for new treatments to alleviate the overall individual and societal burden from severe depression in Denmark.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Early Multimodular Prevention and Intervention Research Institution (EMPIRI), Psychiatric Centre North Zealand, Copenhagen University Hospital - Mental Health Services CPH.
- Department of Clinical Medicine, University of Copenhagen, Denmark.
Zitieren
APA
Vinberg, M. (2026). New treatments for treatment-resistant depression: esketamine controversies – a narrative review. Danish Medical Journal, 1-9. https://doi.org/10.61409/a02260078
Vancouver
Vinberg M. New treatments for treatment-resistant depression: esketamine controversies – a narrative review. Danish Medical Journal. 2026:1-9. doi:10.61409/a02260078
BibTeX
@article{Vinberg2026,
author = {Vinberg, Maj},
title = {New treatments for treatment-resistant depression: esketamine controversies – a narrative review},
journal = {Danish Medical Journal},
year = {2026},
pages = {1--9},
doi = {10.61409/a02260078}
}
EUVIMED